{"id":577,"date":"2018-11-05T13:57:25","date_gmt":"2018-11-05T13:57:25","guid":{"rendered":"http:\/\/www.irlab.se\/corporate-governance\/board-of-directors\/"},"modified":"2026-03-05T22:09:22","modified_gmt":"2026-03-05T21:09:22","slug":"board-of-directors","status":"publish","type":"page","link":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/","title":{"rendered":"Styrelse"},"content":{"rendered":"\n<h1 class=\"wp-block-heading\" id=\"styrelse\">Styrelse<\/h1>\n\n\n\n<p class=\"is-style-intro-text-style\">P\u00e5 \u00e5rsst\u00e4mman den 11 juni 2025 valdes fem styrelseledam\u00f6ter. Styrelsen har utsett ett revisionsutskott och ett ers\u00e4ttningsutskott. En \u00f6versikt av styrelseledam\u00f6terna \u00e5terfinns i tabellen nedan och en presentation av varje ledamot finns l\u00e4ngre ned.<\/p>\n\n\n\n<table id=\"tablepress-3\" class=\"tablepress tablepress-id-3\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Namn<\/th><th class=\"column-2\">Befattning i styrelse<\/th><th class=\"column-3\">Revisionsutskott<\/th><th class=\"column-4\">Ers\u00e4ttningsutskott<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\">Carola Lemne<\/td><td class=\"column-2\">Ordf\u00f6rande<\/td><td class=\"column-3\"><\/td><td class=\"column-4\">Ordf\u00f6rande<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">Christer Nordstedt<\/td><td class=\"column-2\">Ledamot<\/td><td class=\"column-3\"><\/td><td class=\"column-4\">Ledamot<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">Gunnar Olsson<\/td><td class=\"column-2\">Ledamot<\/td><td class=\"column-3\"><\/td><td class=\"column-4\"><\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">Rein Piir<\/td><td class=\"column-2\">Ledamot<\/td><td class=\"column-3\">Ledamot<\/td><td class=\"column-4\"><\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">Veronica Wallin<\/td><td class=\"column-2\">Ledamot<\/td><td class=\"column-3\">Ordf\u00f6rande<\/td><td class=\"column-4\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-3 from cache -->\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"761\" height=\"1024\" src=\"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Carola_Lemne_IRLAB_WEB_761_1084.jpg\" alt=\"\" class=\"wp-image-8874\" srcset=\"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Carola_Lemne_IRLAB_WEB_761_1084.jpg 761w, https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Carola_Lemne_IRLAB_WEB_761_1084-223x300.jpg 223w\" sizes=\"auto, (max-width: 761px) 100vw, 761px\" \/><\/figure>\n\n\n\n<p>Carola Lemne<\/p>\n\n\n\n<p>Ordf\u00f6rande, f\u00f6dd 1958<br>Invald i styrelsen 2019<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p><em>Utbildning och bakgrund:&nbsp;<\/em>MD, PhD och docent vid Karolinska Institutet. Tidigare VD f\u00f6r Svenskt N\u00e4ringsliv och Danderyds Sjukhus AB samt tidigare koncernchef f\u00f6r Praktikertj\u00e4nst AB, klinisk forskningschef och chef f\u00f6r global strategisk l\u00e4kemedelsutveckling och regulatorisk strategi p\u00e5 Pharmacia Corp. Carola Lemne har haft styrelseuppdrag i Getinge, Apoteket, MEDA, Investor och AFA F\u00f6rs\u00e4kringar och har \u00e4ven varit styrelseledamot av Stiftelsen f\u00f6r Strategisk Forskning, Statliga delegationen f\u00f6r klinisk forskning, Stockholms Universitet, Institutet f\u00f6r N\u00e4ringslivsforskning och Kollegiet f\u00f6r Svensk Bolagsstyrning, samt ordf\u00f6rande f\u00f6r Uppsala Universitet, Internationella Engelska SKolan och ARtClinicAB.<\/p>\n\n\n\n<p><em>P\u00e5g\u00e5ende uppdrag<\/em>: Styrelseordf\u00f6rande i Ung F\u00f6retagsamhet Sverige och UF Support AB samt ordf\u00f6rande i SAmhall AB. Styrelseledamot i Arjo AB (publ), Calgo Enterprise AB, Sophiahemmet Ideell f\u00f6rening, Sophiahemmet AB, Terveystalo Oy (publ) samt Hj\u00e4rt-Lungfonden.<\/p>\n\n\n\n<p><em>Aktieinnehav<\/em>: 46 500 A-aktier.<\/p>\n\n\n\n<p><em>Bed\u00f6ms oberoende i f\u00f6rh\u00e5llande till bolaget, dess ledning och st\u00f6rre aktie\u00e4gare.<\/em><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-sand-color has-css-opacity has-sand-background-color has-background is-style-wide\"\/>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"436\" height=\"588\" src=\"https:\/\/irlab.se\/wp-content\/uploads\/2023\/07\/Christer-Nordstedt-sv.jpg\" alt=\"\" class=\"wp-image-10874\" srcset=\"https:\/\/irlab.se\/wp-content\/uploads\/2023\/07\/Christer-Nordstedt-sv.jpg 436w, https:\/\/irlab.se\/wp-content\/uploads\/2023\/07\/Christer-Nordstedt-sv-222x300.jpg 222w\" sizes=\"auto, (max-width: 436px) 100vw, 436px\" \/><\/figure>\n\n\n\n<p>Christer Nordstedt<\/p>\n\n\n\n<p>f\u00f6dd 1962<br>Invald i styrelsen 2023<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p><em>Utbildning och bakgrund<\/em>: L\u00e4kare, medicine doktor och docent inom farmakologi och biokemi vid Karolinska<br>Institutet. Forskarutbildning hos nobelpristagaren Paul Greengard vid Rockefeller University i New<br>York.<\/p>\n\n\n\n<p>Mer \u00e4n tjugo\u00e5rig internationell erfarenhet som forsknings- och<br>f\u00f6retagsledare inom l\u00e4kemedelsindustrin. Innehaft befattningar s\u00e5som global forskningschef f\u00f6r innovativa l\u00e4kemedel p\u00e5 Teva Pharmaceuticals, ansvarig f\u00f6r forskning och utveckling hos Orion Cooperation, Vice President hos AstraZeneca, Senior Vice President hos Hoffman-LaRoche och Eli Lilly. Tidigare styrelsemedlem i Orion Diagnostics och Fermion samt VD f\u00f6r Vivesto AB. F\u00f6r n\u00e4rvarande VD f\u00f6r Oblique Therapeutics AB (publ) och dess dotterbolag CINDA PHARMA AB.<\/p>\n\n\n\n<p><em>P\u00e5g\u00e5ende uppdrag<\/em>: Styrelseordf\u00f6rande i Wntresearch AB och Snevringe AB. Styrelseledamot i CINDA PHARMA AB<\/p>\n\n\n\n<p><em>Aktieinnehav<\/em>: Nej.<\/p>\n\n\n\n<p><em>Bed\u00f6ms oberoende i f\u00f6rh\u00e5llande till bolaget och dess ledning men inte till dess st\u00f6rre aktie\u00e4gare.<\/em><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-sand-color has-css-opacity has-sand-background-color has-background is-style-wide\"\/>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"761\" height=\"1024\" src=\"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Gunnar_Olsson_IRLAB_WEB_761_1084.jpg\" alt=\"\" class=\"wp-image-8880\" srcset=\"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Gunnar_Olsson_IRLAB_WEB_761_1084.jpg 761w, https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Gunnar_Olsson_IRLAB_WEB_761_1084-223x300.jpg 223w\" sizes=\"auto, (max-width: 761px) 100vw, 761px\" \/><\/figure>\n\n\n\n<p>Gunnar Olsson<\/p>\n\n\n\n<p>f\u00f6dd 1953<br>Invald i styrelsen 2017<br><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p><em>Utbildning och bakgrund<\/em>: MD, PhD, docent vid Karolinska Institutet, medicine hedersdoktor vid G\u00f6teborgs Universitet. Adjungerad professor vid Karolinska Institutet 1998-2010. Mer \u00e4n 35 \u00e5rs erfarenhet inom life science f\u00f6retag. Innehaft ledande befattningar inom AstraZeneca under 25 \u00e5r, varav 10 \u00e5r som ledare f\u00f6r terapiomr\u00e5dena Cardiovascular and Gastro-intestinal inom Global R&amp;D. Varit ansvarig f\u00f6r utveckling av sju globala blockbusters\/mega-l\u00e4kemedel. Sedan 2013 innehaft styrelse- och konsult uppdrag i bio-tech f\u00f6retag sprungna ur svensk akademisk forskning. VD i IRLAB 2023-2024.<\/p>\n\n\n\n<p><em>P\u00e5g\u00e5ende uppdrag<\/em>: Vice styrelseordf\u00f6rande i Hj\u00e4rt och Lungfonden Svenska Nationalf\u00f6reningen mot hj\u00e4rt och lungsjukdomar och i Bundy Academy vid Lunds universitet. Styrelseledamot i Amplifier Tx AB, Betagenon AB, Betagenon Bio AB, Cereno Scientific AB och Olsson Solutions AB. Bolagsman i Olsson Solutions Kommanditbolag.<\/p>\n\n\n\n<p><em>Aktieinnehav<\/em>: 19 500 A-aktier.<\/p>\n\n\n\n<p><em><em>Bed\u00f6ms oberoende i f\u00f6rh\u00e5llande till bolaget, dess ledning och st\u00f6rre aktie\u00e4gare.<\/em><\/em><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-sand-color has-css-opacity has-sand-background-color has-background is-style-wide\"\/>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"761\" height=\"1024\" src=\"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Rein_Piir_IRLAB_WEB_761_1084.jpg\" alt=\"\" class=\"wp-image-8894\" srcset=\"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Rein_Piir_IRLAB_WEB_761_1084.jpg 761w, https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Rein_Piir_IRLAB_WEB_761_1084-223x300.jpg 223w\" sizes=\"auto, (max-width: 761px) 100vw, 761px\" \/><\/figure>\n\n\n\n<p>Rein Piir<\/p>\n\n\n\n<p>f\u00f6dd 1958<br>Invald i styrelsen 2016<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p><em>Utbildning och bakgrund: <\/em>Civilekonom med BSc i F\u00f6retagsekonomi och ledning vid Uppsala universitet.&nbsp;35 \u00e5rs erfarenhet av r\u00e5dgivning inom kapitalmarknadsfr\u00e5gor och finansiering. Innehaft positioner som analyschef p\u00e5 Carnegie Investment Bank, strateg Alecta, CFO\/IR-chef Medivir samt revisor p\u00e5 PricewaterhouseCoopers AB, IR-ansvarig p\u00e5 Oncopeptides AB samt, genom Piir &amp; Partner AB, behj\u00e4lplig med arbetet kring investerarrelationer p\u00e5 Camurus AB.<\/p>\n\n\n\n<p><em>P\u00e5g\u00e5ende uppdrag:<\/em> Styrelseordf\u00f6rande i Piir &amp; Partner AB. Styrelseledamot i L. E. Svensson Snickeri Aktiebolag.<\/p>\n\n\n\n<p><em>Aktieinnehav:<\/em> 63 633 A-aktier och 5 567 B-aktier via bolag\/n\u00e4rst\u00e5ende.<\/p>\n\n\n\n<p><em>Bed\u00f6ms oberoende i f\u00f6rh\u00e5llande till bolaget, dess ledning och st\u00f6rre aktie\u00e4gare.<\/em><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-sand-color has-css-opacity has-sand-background-color has-background is-style-wide\"\/>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"315\" height=\"468\" src=\"https:\/\/irlab.se\/wp-content\/uploads\/2023\/07\/Veronica-Wallin-sv.jpg\" alt=\"\" class=\"wp-image-10862\" srcset=\"https:\/\/irlab.se\/wp-content\/uploads\/2023\/07\/Veronica-Wallin-sv.jpg 315w, https:\/\/irlab.se\/wp-content\/uploads\/2023\/07\/Veronica-Wallin-sv-202x300.jpg 202w\" sizes=\"auto, (max-width: 315px) 100vw, 315px\" \/><\/figure>\n\n\n\n<p>Veronica Wallin<\/p>\n\n\n\n<p>f\u00f6dd 1986<br>Invald i styrelsen 2023<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p><em>Utbildning och bakgrund:<\/em> Magisterexamen i f\u00f6retagsekonomi vid Stockholms universitet. Studier inom marknadsf\u00f6ring, PR, kommunikation och redovisning vid The State University of New York at New Paltz. 10-\u00e5rig erfarenhet inom Life Science, bland annat genom styrelseuppdrag och ledande positioner i bolag inom branschen. Innehaft positioner som styrelseledamot i Alligator Bioscience, CFO p\u00e5 medicinteknikbolaget Episurf Medical AB och apoteksbolaget ApoEx AB samt som revisor p\u00e5 BDO. F\u00f6r n\u00e4rvarande CFO p\u00e5 4C Group AB.<\/p>\n\n\n\n<p><em>P\u00e5g\u00e5ende uppdrag:<\/em> Styrelseledamot i Board member of 4C Strategies AB, 4C International AB, 4C Europe UK Limited,  Episurf DE GmbH and Episurf India Limited.<\/p>\n\n\n\n<p><em>Aktieinnehav:<\/em> 22 700 A-aktier personligen samt via kapitalf\u00f6rs\u00e4kring.<\/p>\n\n\n\n<p><em>Bed\u00f6ms oberoende i f\u00f6rh\u00e5llande till bolaget, dess ledning och st\u00f6rre aktie\u00e4gare.<\/em><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-sand-color has-css-opacity has-sand-background-color has-background is-style-wide\"\/>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-sand-color has-css-opacity has-sand-background-color has-background is-style-wide\"\/>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-small-font-size\"><em>P\u00e5g\u00e5ende uppdrag avser hos Bolagsverket registrerade uppdrag per den 30 april 2025 och innefattar inte uppdrag inom IRLAB-koncernen. <em>Aktieinnehav avser innehav f\u00f6r av Bolaget k\u00e4nda f\u00f6r\u00e4ndringar fram till den 14 november 2025.<\/em><\/em><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Styrelse P\u00e5 \u00e5rsst\u00e4mman den 11 juni 2025 valdes fem styrelseledam\u00f6ter. Styrelsen har utsett ett revisionsutskott och ett ers\u00e4ttningsutskott. En \u00f6versikt av styrelseledam\u00f6terna \u00e5terfinns i tabellen nedan och en presentation av varje ledamot finns l\u00e4ngre ned. Carola Lemne Ordf\u00f6rande, f\u00f6dd 1958Invald i styrelsen 2019 Utbildning och bakgrund:&nbsp;MD, PhD och docent vid Karolinska Institutet. Tidigare VD f\u00f6r [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":612,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-577","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Styrelse - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Styrelse - IRLAB\" \/>\n<meta property=\"og:description\" content=\"Styrelse P\u00e5 \u00e5rsst\u00e4mman den 11 juni 2025 valdes fem styrelseledam\u00f6ter. Styrelsen har utsett ett revisionsutskott och ett ers\u00e4ttningsutskott. En \u00f6versikt av styrelseledam\u00f6terna \u00e5terfinns i tabellen nedan och en presentation av varje ledamot finns l\u00e4ngre ned. Carola Lemne Ordf\u00f6rande, f\u00f6dd 1958Invald i styrelsen 2019 Utbildning och bakgrund:&nbsp;MD, PhD och docent vid Karolinska Institutet. Tidigare VD f\u00f6r [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-05T21:09:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Carola_Lemne_IRLAB_WEB_761_1084.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"761\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/\",\"url\":\"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/\",\"name\":\"Styrelse - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Carola_Lemne_IRLAB_WEB_761_1084.jpg\",\"datePublished\":\"2018-11-05T13:57:25+00:00\",\"dateModified\":\"2026-03-05T21:09:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#primaryimage\",\"url\":\"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Carola_Lemne_IRLAB_WEB_761_1084.jpg\",\"contentUrl\":\"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Carola_Lemne_IRLAB_WEB_761_1084.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Om IRLAB\",\"item\":\"https:\/\/irlab.se\/sv\/om-irlab\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Styrelse\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Styrelse - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/","og_locale":"sv_SE","og_type":"article","og_title":"Styrelse - IRLAB","og_description":"Styrelse P\u00e5 \u00e5rsst\u00e4mman den 11 juni 2025 valdes fem styrelseledam\u00f6ter. Styrelsen har utsett ett revisionsutskott och ett ers\u00e4ttningsutskott. En \u00f6versikt av styrelseledam\u00f6terna \u00e5terfinns i tabellen nedan och en presentation av varje ledamot finns l\u00e4ngre ned. Carola Lemne Ordf\u00f6rande, f\u00f6dd 1958Invald i styrelsen 2019 Utbildning och bakgrund:&nbsp;MD, PhD och docent vid Karolinska Institutet. Tidigare VD f\u00f6r [&hellip;]","og_url":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/","og_site_name":"IRLAB","article_modified_time":"2026-03-05T21:09:22+00:00","og_image":[{"width":761,"height":1024,"url":"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Carola_Lemne_IRLAB_WEB_761_1084.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"5 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/","url":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/","name":"Styrelse - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"primaryImageOfPage":{"@id":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Carola_Lemne_IRLAB_WEB_761_1084.jpg","datePublished":"2018-11-05T13:57:25+00:00","dateModified":"2026-03-05T21:09:22+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#primaryimage","url":"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Carola_Lemne_IRLAB_WEB_761_1084.jpg","contentUrl":"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Carola_Lemne_IRLAB_WEB_761_1084.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"Om IRLAB","item":"https:\/\/irlab.se\/sv\/om-irlab\/"},{"@type":"ListItem","position":3,"name":"Styrelse"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=577"}],"version-history":[{"count":95,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/577\/revisions"}],"predecessor-version":[{"id":12839,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/577\/revisions\/12839"}],"up":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/612"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}